Loading...

PE/Cyanine7 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_PECyanine7_CD11c_Antibody_1_111924
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (left) or PE/Cyanine7 Armenian hamster IgG isotype control (right)
  • N418_PECyanine7_CD11c_Antibody_1_111924
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (left) or PE/Cyanine7 Armenian hamster IgG isotype control (right)
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
117317 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117318 100 µg 185€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  2. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  3. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  4. Al–Rashed F, et al. 2020. Sci Rep. 10:16802. PubMed
  5. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  6. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  7. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  8. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  9. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  10. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  11. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  12. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  13. Osokine I, et al. 2022. Cell Rep. 38:110329. PubMed
  14. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  15. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  16. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  17. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  18. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  19. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  20. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  21. Hill AA, et al. 2023. JCI Insight. 8: . PubMed
  22. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  23. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  24. Cousin N, et al. 2022. Cells. 12: . PubMed
  25. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  26. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  27. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  28. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  29. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  30. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  31. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  32. Morris CR, et al. 2022. Mucosal Immunol. 15:977. PubMed
  33. Kedmi R, et al. 2022. Nature. 610:737. PubMed
  34. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  35. Lutz MB, et al. 2022. Eur J Immunol. . PubMed
  36. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  37. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  38. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  39. Rocca Y, et al. 2023. Methods Mol Biol. 2618:187. PubMed
  40. Xu H, et al. 2023. Elife. 12:. PubMed
  41. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  42. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  43. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  44. He Y, et al. 2023. Biomolecules. 13:. PubMed
  45. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  46. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  47. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  48. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  49. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  50. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  51. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  52. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  53. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  54. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  55. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  56. Kolawole A, et al. 2015. J Virol. 90: 1499-1506. PubMed
  57. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  58. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  59. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  60. Thwe PM et al. 2017. Cell metabolism. 26(3):558-567 . PubMed
  61. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  62. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  63. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  64. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  65. Boldison J, et al. 2020. Cell Mol Immunol. 17:843. PubMed
  66. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  67. Suzuki T, et al. 2014. J Dermatol Sci. 74:116. PubMed
  68. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  69. Ndoja A, et al. 2020. Cell. 182(5):1156-1169.e12. PubMed
  70. Dong L, et al. 2021. Cancer Cell. . PubMed
  71. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  72. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  73. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  74. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  75. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  76. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  77. Yu X, et al. 2021. Nature. 594:560. PubMed
  78. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  79. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  80. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  81. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  82. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  83. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  84. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  85. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  86. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  87. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  88. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  89. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  90. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  91. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  94. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  95. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  96. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  97. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  98. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  99. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  100. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  101. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  102. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  103. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  104. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  105. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  106. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  107. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  108. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  109. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  110. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  111. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  112. Wu X, et al. 2021. Elife. 10:. PubMed
  113. Škrnjug I, et al. 2014. PLoS One. 9:110150. PubMed
  114. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  115. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  116. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  117. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  118. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  119. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  120. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  121. Crosse EI, et al. 2020. Cell Stem Cell. 27:822. PubMed
  122. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  123. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  124. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  125. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  126. Baudoux T, et al. 2018. Sci Rep. 4.0375. PubMed
  127. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  128. Pan Y, et al. 2022. J Clin Invest. 132:. PubMed
  129. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  130. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  131. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  132. Connick K, et al. 2020. J Parasit Dis. 186:44. PubMed
  133. Johnson LA, et al. 2021. Life Sci Alliance. :4. PubMed
  134. Christ A, et al. 2018. Cell. 172:162. PubMed
  135. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  136. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  137. Krollmann C, et al. 2022. STAR Protoc. 3:101309. PubMed
  138. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  139. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  140. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  141. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  142. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  143. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  144. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  145. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  146. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  147. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  148. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  149. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  150. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  151. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  152. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  153. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  154. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  155. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  156. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  157. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  158. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  159. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  160. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  161. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  162. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  163. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  164. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  165. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  166. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  167. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  168. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  169. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  170. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  171. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  172. Yang X, et al. 2022. Front Immunol. 13:856230. PubMed
  173. Colliou N, et al. 2015. Toxins. 7: 3805 - 3817. PubMed
  174. Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
  175. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  176. Lan H, et al. 2020. Int Immunol. 559:32. PubMed
  177. Kim M, et al. 2018. Immunity. 49:151. PubMed
  178. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  179. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  180. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  181. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  182. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  183. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  184. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  185. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  186. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  187. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  188. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  189. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  190. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  191. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  192. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  193. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  194. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  195. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  196. Hennion-Tscheltzoff O, et al. 2013. Blood. 121:4684. PubMed
  197. Škrnjug I, et al. 2014. PLoS One. 9:95728. PubMed
  198. Velázquez F, et al. 2016. J Immunol. 196: 1305 - 1316. PubMed
  199. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  200. Yasuda T, et al. 2016. PLoS One. 11:e0167952. PubMed
  201. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  202. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  203. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  204. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  205. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  206. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  207. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  208. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  209. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  210. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  211. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  212. Okreglicka K, et al. 2021. J Exp Med. 218:. PubMed
  213. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  214. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  215. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  216. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  217. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  218. Schuh E, et al. 2017. J Immunol. 198:3081. PubMed
  219. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  220. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  221. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  222. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  223. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  224. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  225. Lee HN, et al. 2022. JCI Insight. 7:. PubMed
  226. Verma M, et al. 2021. J Exp Med. 218:. PubMed
  227. Kim J, et al. 2020. Adv Funct Mater. 30:. PubMed
  228. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  229. Van Nuffel E, et al. 2020. EMBO Rep. 21:e49237. PubMed
  230. Liu SS, et al. 2021. Immunity. :. PubMed
  231. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  232. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  233. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  234. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  235. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  236. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  237. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  238. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  239. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  240. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  241. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  242. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  243. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  244. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  245. Dietschmann A, et al. 2020. Eur J Immunol. 50:1044. PubMed
  246. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  247. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  248. Goc J, et al. 2021. Cell. 184:5015. PubMed
  249. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  250. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  251. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  252. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  254. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  255. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  256. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  257. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  258. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  259. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_493568 (BioLegend Cat. No. 117317)
AB_493568 (BioLegend Cat. No. 117318)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account